BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 14977865)

  • 1. Identification of human UDP-glucuronosyltransferase enzyme(s) responsible for the glucuronidation of ezetimibe (Zetia).
    Ghosal A; Hapangama N; Yuan Y; Achanfuo-Yeboah J; Iannucci R; Chowdhury S; Alton K; Patrick JE; Zbaida S
    Drug Metab Dispos; 2004 Mar; 32(3):314-20. PubMed ID: 14977865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regioselective glucuronidation of denopamine: marked species differences and identification of human udp-glucuronosyltransferase isoform.
    Kaji H; Kume T
    Drug Metab Dispos; 2005 Mar; 33(3):403-12. PubMed ID: 15608137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epirubicin glucuronidation is catalyzed by human UDP-glucuronosyltransferase 2B7.
    Innocenti F; Iyer L; Ramírez J; Green MD; Ratain MJ
    Drug Metab Dispos; 2001 May; 29(5):686-92. PubMed ID: 11302935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of human UDP-glucuronosyltransferase enzyme(s) responsible for the glucuronidation of 3-hydroxydesloratadine.
    Ghosal A; Yuan Y; Hapangama N; Su AD; Alvarez N; Chowdhury SK; Alton KB; Patrick JE; Zbaida S
    Biopharm Drug Dispos; 2004 Sep; 25(6):243-52. PubMed ID: 15334623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disposition of the selective cholesterol absorption inhibitor ezetimibe in healthy male subjects.
    Patrick JE; Kosoglou T; Stauber KL; Alton KB; Maxwell SE; Zhu Y; Statkevich P; Iannucci R; Chowdhury S; Affrime M; Cayen MN
    Drug Metab Dispos; 2002 Apr; 30(4):430-7. PubMed ID: 11901097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carboxyl-glucuronidation of mitiglinide by human UDP-glucuronosyltransferases.
    Yu L; Lu S; Lin Y; Zeng S
    Biochem Pharmacol; 2007 Jun; 73(11):1842-51. PubMed ID: 17359941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro glucuronidation of thyroxine and triiodothyronine by liver microsomes and recombinant human UDP-glucuronosyltransferases.
    Tong Z; Li H; Goljer I; McConnell O; Chandrasekaran A
    Drug Metab Dispos; 2007 Dec; 35(12):2203-10. PubMed ID: 17875670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of 2-[[4-[[2-(1H-tetrazol-5-ylmethyl)phenyl]methoxy]methyl]quinoline N-glucuronidation by in vitro and in vivo approaches.
    Stevens JC; Fayer JL; Cassidy KC
    Drug Metab Dispos; 2001 Mar; 29(3):289-95. PubMed ID: 11181497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trans-3'-hydroxycotinine O- and N-glucuronidations in human liver microsomes.
    Yamanaka H; Nakajima M; Katoh M; Kanoh A; Tamura O; Ishibashi H; Yokoi T
    Drug Metab Dispos; 2005 Jan; 33(1):23-30. PubMed ID: 15470160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Product inhibition of UDP-glucuronosyltransferase (UGT) enzymes by UDP obfuscates the inhibitory effects of UGT substrates.
    Fujiwara R; Nakajima M; Yamanaka H; Katoh M; Yokoi T
    Drug Metab Dispos; 2008 Feb; 36(2):361-7. PubMed ID: 17998297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. UDP-glucuronosyltransferase 1A1 is the principal enzyme responsible for etoposide glucuronidation in human liver and intestinal microsomes: structural characterization of phenolic and alcoholic glucuronides of etoposide and estimation of enzyme kinetics.
    Wen Z; Tallman MN; Ali SY; Smith PC
    Drug Metab Dispos; 2007 Mar; 35(3):371-80. PubMed ID: 17151191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human UDP-glucuronosyltransferase isoforms involved in bisphenol A glucuronidation.
    Hanioka N; Naito T; Narimatsu S
    Chemosphere; 2008 Dec; 74(1):33-6. PubMed ID: 18990428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A humanized UGT1 mouse model expressing the UGT1A1*28 allele for assessing drug clearance by UGT1A1-dependent glucuronidation.
    Cai H; Nguyen N; Peterkin V; Yang YS; Hotz K; La Placa DB; Chen S; Tukey RH; Stevens JC
    Drug Metab Dispos; 2010 May; 38(5):879-86. PubMed ID: 20124398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of human UDP-glucuronyltransferases on the formation of the methylenedioxymethamphetamine (ecstasy) phase II metabolites R- and S-3-methoxymethamphetamine 4-O-glucuronides.
    Schwaninger AE; Meyer MR; Zapp J; Maurer HH
    Drug Metab Dispos; 2009 Nov; 37(11):2212-20. PubMed ID: 19666989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of human UGT2B7 as the major isoform involved in the O-glucuronidation of chloramphenicol.
    Chen M; LeDuc B; Kerr S; Howe D; Williams DA
    Drug Metab Dispos; 2010 Mar; 38(3):368-75. PubMed ID: 20008037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of multiple UDP-glucuronosyltransferase 1A isoforms in glucuronidation of 5-(4'-hydroxyphenyl)-5-phenylhydantoin in human liver microsomes.
    Nakajima M; Sakata N; Ohashi N; Kume T; Yokoi T
    Drug Metab Dispos; 2002 Nov; 30(11):1250-6. PubMed ID: 12386132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human metabolism of nebicapone (BIA 3-202), a novel catechol-o-methyltransferase inhibitor: characterization of in vitro glucuronidation.
    Loureiro AI; Bonifácio MJ; Fernandes-Lopes C; Almeida L; Wright LC; Soares-Da-Silva P
    Drug Metab Dispos; 2006 Nov; 34(11):1856-62. PubMed ID: 16790555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucuronidation of etoposide in human liver microsomes is specifically catalyzed by UDP-glucuronosyltransferase 1A1.
    Watanabe Y; Nakajima M; Ohashi N; Kume T; Yokoi T
    Drug Metab Dispos; 2003 May; 31(5):589-95. PubMed ID: 12695347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of UDP-glucuronosyltransferases responsible for the glucuronidation of darexaban, an oral factor Xa inhibitor, in human liver and intestine.
    Shiraga T; Yajima K; Suzuki K; Suzuki K; Hashimoto T; Iwatsubo T; Miyashita A; Usui T
    Drug Metab Dispos; 2012 Feb; 40(2):276-82. PubMed ID: 22031623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a novel N-carbamoyl glucuronide: in vitro, in vivo, and mechanistic studies.
    Gunduz M; Argikar UA; Baeschlin D; Ferreira S; Hosagrahara V; Harriman S
    Drug Metab Dispos; 2010 Mar; 38(3):361-7. PubMed ID: 20008038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.